ITI Pharma and Healthcare Fund Direct Growth
ITI Pharma and Healthcare Fund Direct Growth: NAV ₹20.57, 3Y return 19.87%, 5Y 15.61%, AUM ₹263 Cr, expense ratio 0.86%, iNVESTT rating 5/5. Returns vs index, rolling returns, holdings, Direct vs Regular and peers, by a SEBI Registered Research Analyst.
Key facts
- NAV
- ₹20.5712 (19 Nov 2026)
- 1-year return
- 17.09%
- 3-year return (CAGR)
- 19.87%
- 5-year return (CAGR)
- 15.61%
- Fund size (AUM)
- ₹263 Cr
- Expense ratio
- 0.86%
- Exit load
- If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50% Exit Load after completion of 3 months - NIL
- Minimum investment
- Rs. 5,000/- and in multiples of Rs. 1/- thereafter
- Category
- Sectoral/Thematic Funds
- Benchmark
- Nifty Healthcare Total Return Index
- Riskometer
- Very High Risk
- Fund manager
- Mr. Animesh Singh, Mr. Nilay Dalal
- Launch date
- 18 Oct 2021
- iNVESTT rating
- 5 out of 5
Frequently asked questions
What is the NAV of ITI Pharma and Healthcare Fund Direct Growth today?
The NAV of ITI Pharma and Healthcare Fund Direct Growth is ₹20.5712 as of 19 Nov 2026.
What are the returns of ITI Pharma and Healthcare Fund Direct Growth?
17.09% over 1 year, 19.87% a year over 3 years, 15.61% a year over 5 years. Past returns do not guarantee future returns; compare them with the benchmark and rolling returns on this page.
What is the expense ratio of ITI Pharma and Healthcare Fund Direct Growth?
The expense ratio (TER) is 0.86% a year.
What is the AUM (fund size) of ITI Pharma and Healthcare Fund Direct Growth?
ITI Pharma and Healthcare Fund Direct Growth manages ₹263 Cr.
Is there an exit load on ITI Pharma and Healthcare Fund Direct Growth?
Exit load: If redeemed/Switched out on or before 3 Months from the date of allotment; Exit Load is 0.50% Exit Load after completion of 3 months - NIL.
How risky is ITI Pharma and Healthcare Fund Direct Growth?
Its SEBI riskometer is "Very High Risk" and it is in the Sectoral/Thematic Funds category.
What is the benchmark of ITI Pharma and Healthcare Fund Direct Growth?
The benchmark is Nifty Healthcare Total Return Index. This page compares the fund with its benchmark's total-return index (TRI).
What is the iNVESTT rating of ITI Pharma and Healthcare Fund Direct Growth?
5 out of 5. iNVESTT rating: where the fund ranks in its category over 1, 3 and 5 years (3 and 5 years count most). Top fifth = 5 stars. A past-performance measure, not a recommendation.
Research by iNVESTT, a SEBI Registered Research Analyst (INH000010858). Data from AMFI. Mutual fund investments are subject to market risks; past performance does not guarantee future returns.